Drug addiction is a chronic brain disorder characterized by compulsive substance use despite harmful consequences — driven by neurobiological changes in the brain’s reward, motivation, and decision-making pathways that impair a person’s ability to control their behavior. Per the DSM-5, healthcare professionals diagnose it formally as substance use disorder (SUD), a medical condition that requires professional treatment rather than willpower alone. 

According to SAMHSA, an estimated 5.4 million Californians — roughly 17% of those age 12 and older — had a substance use disorder in 2023, while only about 1 in 10 Californians with SUD receives any form of treatment in a given year. Understanding what drug addiction is, how it develops, and what effective treatment looks like is the first step toward recovery.

Key Takeaways

• Drug addiction is a diagnosable, treatable brain disorder — not a moral failing — characterized by compulsive substance use despite harmful consequences and driven by measurable changes in brain chemistry.
• Genetic factors contribute approximately 40–60% of addiction vulnerability; the remainder comes from environmental, psychological, and social risk factors that interact over time.
• An estimated 5.4 million Californians had a substance use disorder in 2023; drug overdose is now the leading cause of death for Californians aged 18 to 44, with fentanyl involved in the vast majority of opioid deaths.
• The DSM-5 diagnoses substance use disorder when 2 or more of 11 criteria are present — ranging from mild (2–3 criteria) to severe (6+); this replaces older terms like “abuse” and “dependence.”
• Co-occurring mental health conditions — depression, anxiety, PTSD — are present in the majority of people with SUD and must be treated simultaneously through a dual diagnosis approach.
• Evidence-based treatment includes medical detox, medication-assisted treatment (MAT), behavioral therapies such as CBT and DBT, and structured levels of care from residential through outpatient.
• Only about 1 in 10 Californians with a substance use disorder receives treatment each year; the Mental Health Parity Act requires most insurance plans to cover SUD treatment at parity with medical benefits.

What Is the Definition of Drug Addiction?

Drug addiction is defined by the DSM-5 as a substance use disorder — a chronic, relapsing brain disease involving loss of control over substance use, compulsive use despite significant harm, and persistent craving. 

The condition involves neurobiological changes in the brain’s reward circuitry, stress response systems, and prefrontal cortex — areas governing pleasure, impulse control, and decision-making — that sustain compulsive use even when a person is motivated to stop. These changes are measurable, long-lasting, and distinct from the short-term intoxication effects of any individual substance.

What Is the Difference Between Addiction, Dependence, and Substance Abuse?

These three terms are frequently conflated but have distinct clinical meanings:

Term	Clinical Definition	Key Feature
Physical dependence	Neurobiological adaptation requiring a substance for normal function; withdrawal occurs upon cessation	Can develop with prescribed medications in compliant patients; does not require compulsive use
Substance abuse	Older DSM-IV term for harmful use patterns without physical dependence	Replaced by the unified “substance use disorder” in DSM-5
Substance use disorder / Addiction	Compulsive use, loss of control, and continued use despite harm; includes neurobiological and behavioral criteria	Requires 2+ of 11 DSM-5 criteria; ranges from mild to severe

Physical dependence is not the same as addiction. A patient who develops withdrawal symptoms after stopping a medication prescribed for legitimate medical use may be physically dependent but does not necessarily have a use disorder. Addiction involves compulsive drug-seeking behavior and continued use despite serious negative consequences — the defining features of the disease.

How Common Is Drug Addiction in the United States and California?

Drug addiction is one of the most prevalent and undertreated medical conditions in the United States. Per SAMHSA’s 2023 National Survey on Drug Use and Health, an estimated 54.2 million Americans aged 12 or older needed substance use disorder treatment in the past year, but only 12.8 million received it. 

In California, approximately 9% of residents met criteria for a substance use disorder in the past year, with 5.4 million Californians affected in 2023. Per CDC data, drug overdose now ranks as the leading cause of accidental death in the U.S., surpassing car accidents — and is the leading cause of death for Californians aged 18 to 44.

What Are the Main Types of Drug Addiction?

The most prevalent types of drug addiction are:

Fentanyl Addiction

Fentanyl is a fully synthetic opioid 50–100 times more potent than morphine and the primary driver of the U.S. overdose crisis — responsible for 72,776 deaths in 2023 and involved in 95% of young adult opioid overdose deaths in California. Illicitly manufactured fentanyl is now found throughout the broader drug supply, including in counterfeit pills disguised as Xanax, Adderall, and Percocet, meaning overdose risk extends to people who never intentionally sought opioids. The DEA confirmed that 5 in 10 counterfeit pills seized in 2024 contained a potentially lethal dose of fentanyl. 

Heroin Addiction

Heroin is a semi-synthetic opioid derived from morphine that produces rapid-onset euphoria through mu-opioid receptor activation, followed by intense sedation and compulsive re-dosing. Heroin-specific overdose deaths have declined sharply — from one-third of California’s opioid fatalities in 2018 to just 3% in 2023 — because the illicit supply has been largely displaced by fentanyl, now detected in approximately 80% of heroin samples. The declining heroin death rate does not reflect reduced danger; it reflects that most people using what they believe to be heroin are now using fentanyl.

Morphine Addiction

Morphine is the natural opioid extracted from the opium poppy against which all other opioid potency is measured. It is prescribed medically for severe pain and post-surgical care, and it remains a foundational substance in opioid use disorder — both as a drug of misuse in its own right and as the neurobiological template for how all opioids produce dependence through mu-opioid receptor activation. Tolerance and physical dependence can develop within days of regular use, with withdrawal beginning 6–12 hours after the last dose.

Oxycodone Addiction

Oxycodone (OxyContin, Percocet) is a semi-synthetic opioid prescribed for moderate-to-severe pain that played a central role in launching the first wave of the opioid epidemic in the 1990s and 2000s. Its reformulation into an abuse-deterrent form in 2010 triggered a mass transition to heroin and eventually illicit fentanyl — demonstrating how prescription opioid dependence creates a direct pipeline to more potent street drugs. Tolerance builds rapidly; withdrawal begins within 12–24 hours of the last dose and includes severe muscle pain, vomiting, and intense craving.

Hydrocodone Addiction

Hydrocodone (Vicodin, Norco) is the most commonly prescribed opioid in the United States and among the most frequently misused, affecting approximately 192,000 Californians with a prescription pain reliever use disorder. It produces analgesia and dose-dependent euphoria through mu-opioid receptor binding; as tolerance develops, patients require increasing doses to achieve pain relief, often exceeding prescribed amounts. Like oxycodone, hydrocodone dependence frequently transitions to illicit opioid use when prescriptions are reduced or discontinued.

Methamphetamine Addiction

Methamphetamine is a powerful synthetic stimulant that forces a massive release of dopamine, norepinephrine, and serotonin — producing intense euphoria and energy followed by a severe dysphoric crash that drives re-dosing compulsion. 

It accounts for 35% of California drug treatment admissions and is the primary stimulant driving the state’s polysubstance overdose crisis, with fentanyl-methamphetamine combination deaths growing more than 5% per quarter since 2020. There are no FDA-approved medications for meth use disorder; Contingency Management is the gold-standard behavioral treatment.

Cocaine Addiction

Cocaine is a short-acting stimulant that blocks the reuptake of dopamine, serotonin, and norepinephrine, producing intense euphoria lasting 20–60 minutes — a brevity that powerfully drives binge patterns and re-dosing compulsion. 

It was involved in 29,449 U.S. overdose deaths in 2023, the majority of which also involved fentanyl contamination of the supply. A unique metabolic risk: when combined with alcohol, cocaine produces cocaethylene — a toxic metabolite associated with an 18-fold increase in cardiac death risk compared to cocaine alone.

Adderall Addiction

Adderall (amphetamine/dextroamphetamine) is an FDA-approved stimulant prescribed for ADHD and narcolepsy that carries significant misuse potential — particularly among college-aged adults using it non-medically for academic performance or weight loss. 

At doses exceeding therapeutic levels, Adderall produces stimulant effects similar to methamphetamine, including dopamine flooding, cardiovascular strain, and psychological dependence. 

Chronic misuse disrupts the brain’s natural dopamine production, producing anhedonia and fatigue during cessation; mixing Adderall with alcohol or other CNS depressants significantly elevates overdose risk.

Alcohol Addiction

Alcohol use disorder is the most common SUD in California, affecting approximately 6.3% of adults — over 2 million residents. Alcohol enhances GABA inhibitory activity and suppresses glutamate, producing disinhibition, sedation, and euphoria; chronic use creates severe physical dependence, and alcohol withdrawal is one of only two substance withdrawal syndromes (alongside benzodiazepines) that can be fatal — producing grand mal seizures and delirium tremens without medically supervised detox. Alcohol-related deaths increased 20% in California from 2018–2019 to 2020–2021, resulting in approximately 19,335 annual deaths and $47 billion in annual economic harm. 

Benzodiazepine Addiction

Benzodiazepines — including Xanax, Valium, Klonopin, and Ativan — are a class of 15 FDA-approved CNS depressants that enhance GABA-A receptor activity to treat anxiety, panic, seizures, insomnia, and alcohol withdrawal. 

Approximately 3.9 million Americans misused benzodiazepines in 2021, and 10,964 benzo-involved overdose deaths were recorded in 2022 — nearly 70% of which also involved fentanyl. 

Physical dependence can develop in as few as 3–6 weeks at prescribed doses; withdrawal is potentially fatal and requires medically supervised tapering. There are no FDA-approved medications for benzo use disorder. 

Xanax (Alprazolam) Addiction

Xanax is the most misused individual benzodiazepine, accounting for approximately 73% of all benzo misuse due to its short half-life (6–12 hours) and rapid onset — pharmacological features that produce more intense reinforcement and more abrupt withdrawal than longer-acting agents like diazepam or clonazepam. 

Alprazolam can cause physical dependence in as few as 3–6 weeks of regular use even at prescribed doses, and abrupt cessation carries a genuine risk of grand mal seizures. Treatment requires a slow, medically supervised taper — often converting to a longer-acting benzodiazepine before gradually reducing the dose over weeks to months.

Marijuana Addiction

Cannabis use disorder is a clinically recognized condition involving compulsive use, tolerance, withdrawal symptoms (irritability, insomnia, decreased appetite), and functional impairment — affecting an estimated 9% of all who use marijuana and up to 17% of those who begin in adolescence. 

Approximately 20% of Californians used marijuana in the past year, with cannabis accounting for roughly 27% of California drug treatment admissions. High-potency THC concentrates — dabs, wax, shatter — substantially elevate the risk of cannabis-induced psychosis and accelerate dependence development compared to traditional flower.

What Are the Symptoms of Drug Addiction?

The common symptoms of drug addiction are listed below:

Behavioral Signs of Drug Addiction

• Using a substance in larger amounts or for longer than intended
  
• Repeated unsuccessful attempts to cut down or stop using
  
• Spending excessive time obtaining, using, or recovering from substances
  
• Abandoning work, family, or recreational responsibilities
  
• Continuing substance use despite clear physical or psychological harm
  
• Social withdrawal from family and friends
  
• Deceptive behavior about substance use
  
• Financial deterioration, including selling possessions or accumulating debt to obtain drugs

Physical Signs of Drug Addiction

• Rapid, unexplained weight gain or weight loss
  
• Disrupted sleep patterns (insomnia or excessive sleeping)
  
• Declining physical appearance and poor personal hygiene
  
• Track marks, skin sores, or injection-related injuries
  
• Changes in pupil size (constricted with opioids, dilated with stimulants)
  
• Tremors, poor coordination, or slowed motor function
  
• Increased tolerance requiring larger amounts of the substance
  
• Withdrawal symptoms when substance use stops
  

Psychological Symptoms of Drug Addiction

• Intense and persistent substance cravings
  
• Mood instability and emotional volatility
  
• Anxiety and panic symptoms
  
• Depression or persistent low mood
  
• Cognitive impairment affecting memory and concentration
  
• Substance-induced psychosis in severe cases
  
• Co-occurring mental health disorders (dual diagnosis)

What Are the Causes of Drug Addiction?

The common causes of drug addiction are listed below:

• Genetic vulnerability: Variations in genes affecting dopamine receptors, opioid receptor sensitivity, GABA signaling, and stress-response pathways increase susceptibility to substance dependence.
  
• Biological development: The adolescent brain is particularly vulnerable because the prefrontal cortex — responsible for impulse control and decision-making — is still developing.
  
• Early trauma and adverse childhood experiences (ACEs): Physical abuse, neglect, household instability, and early exposure to violence increase long-term addiction risk.
  
• Chronic stress and mental health disorders: Depression, anxiety, PTSD, and prolonged stress can drive substance use as a form of self-medication.
  
• Social and peer influences: Living in environments where substance use is normalized or encouraged increases experimentation and continued use.
  
• Socioeconomic pressures: Poverty, unemployment, housing instability, and limited access to healthcare increase addiction vulnerability.
  
• Geographic and community factors: Regions with limited treatment access, higher drug availability, or higher overdose rates show elevated addiction risk.
  
• Structural and systemic inequality: Historical trauma, healthcare disparities, and limited treatment resources contribute to higher addiction risk in marginalized populations.

How Do Mental Health Conditions Increase Addiction Risk?

Co-occurring psychiatric conditions are present in the majority of people with substance use disorders — depression, anxiety, PTSD, bipolar disorder, and ADHD are the most prevalent. Mental health conditions increase addiction risk through three main pathways: self-medication of psychological distress with substances, shared neurobiological vulnerability (the same genetic and brain circuitry alterations that predispose to mood disorders also increase addiction susceptibility), and the neurochemical effects of mental illness symptoms that intensify craving and impair relapse resistance. 

About 1 in 6 California adolescents with major depressive episodes also has a co-occurring substance use disorder — underscoring why dual diagnosis treatment is essential rather than optional.

What Are the Effects of Drug Addiction?

The common effects of drug addiction are listed below:

• Overdose and mortality: Drug overdose is a leading cause of death, particularly among adults aged 18–44.
  
• Cardiovascular disease: Increased risk of heart attack, arrhythmias, and infective endocarditis from injection drug use.
  
• Respiratory complications: Chronic lung disease, respiratory depression, and breathing disorders associated with opioid and inhaled drug use.
  
• Liver disease: Progressive liver damage, cirrhosis, and liver failure associated with alcohol and certain drugs.
  
• Infectious diseases: Higher risk of HIV, Hepatitis C, and bacterial infections from shared injection equipment.
  
• Neurological damage: Cognitive impairment, memory loss, and long-term changes in brain structure and function.
  
• Prenatal and neonatal harm: Prenatal exposure can lead to developmental disorders and neonatal abstinence syndrome.
  
• Family disruption: Financial instability, domestic conflict, child neglect, and intergenerational trauma within affected households.
  
• Community consequences: Increased traffic fatalities, higher emergency department utilization, and strain on healthcare and public safety systems.
  
• Economic burden: Loss of productivity, healthcare costs, and criminal justice expenditures associated with substance misuse.

How Is Drug Addiction Diagnosed?

Drug addiction is diagnosed through clinical evaluation using DSM-5 criteria, which recognize a single spectrum disorder — Substance Use Disorder — replacing the older categories of abuse and dependence. The DSM-5 identifies 11 diagnostic criteria across four domains:

• Impaired control: Using more than intended; failed efforts to cut down; spending excessive time on use; craving.
• Social impairment: Failure to fulfill obligations; continued use despite interpersonal problems; abandonment of activities.
• Risky use: Use in physically hazardous situations; continued use despite physical or psychological harm.
• Pharmacological criteria: Tolerance; withdrawal.

Severity is determined by the number of criteria met: mild (2–3), moderate (4–5), severe (6 or more). Diagnosis is conducted by qualified clinical professionals and may include urine toxicology, validated screening tools (AUDIT, DAST-10, CAGE), physical examination, and psychiatric evaluation for co-occurring mental health conditions. ASAM Level of Care assessment determines the appropriate intensity of treatment setting.

What Are the Treatment Options for Drug Addiction?

What Is Medical Detox?

Medical detoxification is the medically supervised management of withdrawal — the first phase of treatment for patients with physical dependence on alcohol, opioids, benzodiazepines, or other CNS depressants. Detox stabilizes the patient physiologically, prevents life-threatening withdrawal complications (seizures, delirium), and prepares them for ongoing treatment. Detox alone is not addiction treatment — it addresses physical dependence but does not change the psychological and behavioral patterns that sustain compulsive use. Per ASAM guidelines, detox should always be followed by a structured treatment program.

What Levels of Care Are Available for Addiction Treatment?

Addiction treatment follows a continuum of care that matches treatment intensity to clinical severity:

Level of Care	Description	Typical Hours/Week
Medical Detox / Residential	24-hour medically supervised care; acute stabilization	Full-time
Partial Hospitalization Program (PHP)	Structured daily clinical programming; patient lives off-site	20–30 hours
Intensive Outpatient Program (IOP)	Multiple weekly sessions; allows work/family continuation	9–20 hours
Standard Outpatient	Individual and group therapy; maintenance phase	1–8 hours
Sober Living / Aftercare	Structured recovery housing; peer support	Ongoing

Movement between levels follows clinical progress and ASAM criteria — a patient may step up to residential if IOP is insufficient, or step down from PHP to IOP as stability improves.

What Medications Are Used to Treat Drug Addiction?

Medication-assisted treatment (MAT) combines FDA-approved medications with behavioral therapy to treat opioid and alcohol use disorders — the two forms of SUD with the strongest medication evidence base:

• Opioid use disorder: Buprenorphine (Suboxone, Sublocade), methadone, and naltrexone (Vivitrol) are FDA-approved; buprenorphine can be initiated in primary care and telehealth settings. Naloxone (Narcan) is the overdose reversal medication and should be accessible to anyone using opioids.
• Alcohol use disorder: Naltrexone, acamprosate (Campral), and disulfiram (Antabuse) are FDA-approved; naltrexone has the strongest evidence base.
• Stimulant and benzodiazepine use disorders: No FDA-approved medications exist; behavioral treatment and supervised taper (for benzos) are the evidence-based approaches.

Per NIDA, medications for opioid use disorder reduce overdose mortality, increase treatment retention, and improve social functioning — yet only 18% of people with OUD received MOUD in 2023.

What Behavioral Therapies Treat Drug Addiction?

Evidence-based behavioral therapies are effective across all substance use disorders and are most powerful when combined with MAT where applicable:

• Cognitive Behavioral Therapy (CBT): Identifies and restructures substance-related thought patterns and coping skills; well-validated for opioid, stimulant, alcohol, and cannabis use disorders.
• Dialectical Behavior Therapy (DBT): Addresses emotional dysregulation, distress tolerance, and interpersonal effectiveness; particularly effective for patients with co-occurring borderline personality features, trauma, or chronic suicidality.
• Motivational Interviewing (MI): Resolves ambivalence about change; used in early engagement and relapse prevention phases.
• Contingency Management (CM): Provides structured incentives for toxicology-confirmed abstinence; gold-standard behavioral treatment for stimulant use disorder.
• EMDR Therapy: Processes traumatic memories that drive self-medication patterns; highly effective for co-occurring PTSD.

What Holistic Therapies Support Addiction Recovery?

Holistic and experiential therapies address the mind-body dimensions of addiction that behavioral talk therapy alone may not reach:

• Somatic Experiencing: Processes trauma held in the body; addresses the autonomic nervous system dysregulation underlying anxiety, dissociation, and substance craving.
• Equine Therapy: Develops emotional regulation, trust, and nonverbal communication through structured interaction with horses.
• TMS (Transcranial Magnetic Stimulation) Therapy: Non-invasive brain stimulation addressing treatment-resistant depression commonly co-occurring with SUD.
• Vagus Nerve Stimulation: Supports nervous system regulation and stress resilience during early recovery.
• Mindfulness and Affect Regulation: Builds the capacity to tolerate difficult emotions without substance use; disrupts automatic craving-use cycles.

Drug addiction is a chronic, treatable brain disorder — and with the right combination of medical, psychological, and social support, long-term recovery is achievable.

At Worthy Wellness Centerin Carlsbad, California, our multidisciplinary clinical team provides medically supervised detox, PHP, IOP, and outpatient programs with fully integrated dual diagnosis treatment, medication-assisted treatment, and evidence-based therapies including CBT, DBT, EMDR, somatic experiencing, and equine therapy. We treat the whole person — not just the substance. Contact Worthy Wellness Center or verify your insurance to begin today.

Sources

1. NIDA — Drugs, Brains, and Behavior: The Science of Addiction
2. NIDA — Prescription Drug Misuse Overview
3. NIDA — Medications for Opioid Use Disorder
4. SAMHSA — 2023 National Survey on Drug Use and Health
5. CDC — About Overdose Prevention
6. CDC — Drug Overdose Death Rates
7. American Psychiatric Association — DSM-5
8. DEA — Drug Scheduling